MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 110 filers reported holding MEI PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $66,000 | -75.2% | 109,851 | +10.2% | 0.00% | – |
| Q4 2021 | $266,000 | -5.3% | 99,654 | -2.1% | 0.00% | – |
| Q3 2021 | $281,000 | -2.4% | 101,787 | +0.6% | 0.00% | – |
| Q2 2021 | $288,000 | -27.8% | 101,154 | -12.9% | 0.00% | -100.0% |
| Q1 2021 | $399,000 | +27.9% | 116,197 | -1.8% | 0.00% | – |
| Q4 2020 | $312,000 | -7.4% | 118,332 | +9.5% | 0.00% | -100.0% |
| Q3 2020 | $337,000 | -35.4% | 108,023 | -14.6% | 0.00% | 0.0% |
| Q2 2020 | $522,000 | +507.0% | 126,498 | +136.0% | 0.00% | – |
| Q1 2020 | $86,000 | -35.3% | 53,604 | 0.0% | 0.00% | – |
| Q4 2019 | $133,000 | +52.9% | 53,604 | +3.9% | 0.00% | – |
| Q3 2019 | $87,000 | -33.6% | 51,599 | -1.2% | 0.00% | – |
| Q2 2019 | $131,000 | – | 52,249 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |